Risk Scoring System to Predict Mortality in Gastric Cancer with Peritoneal Carcinomatosis

Author(s)

Pereira, Marina Alessandra ; Ramos, Marcus Fernando Kodama Pertille ; Charruf, Amir Zeide ; Dias, Andre Roncon ; Ribeiro Jr, Ulysses

• Document type: Journal article
• Source: MEDICAL SCIENCES; v. 12, n. 2, p. 12-pg., 2024-06-01.

Abstract

Gastric cancer (GC) with peritoneal carcinomatosis (PC) has a particularly unfavorable prognosis. This limited survival raises doubts about which factors confer an extremely worse outcome and which patients could benefit from more aggressive treatments, in an attempt to improve survival and better control the disease. This study aimed to evaluate the survival outcomes of patients with PC due to GC and develop a prognostic score to predict 6-month mortality. We performed an analysis of clinical stage IV GC with PC. Scores were assigned to risk factors and calculated for each patient from nine variables. Among 326 IVB GC, 211 (64.7%) had PC and were included. After calculating the score, 136 (64.5%) GCs were classified as a low-risk group and 75 (35.5%) as a high-risk group. Median OS was 7.9 and 1.9 months for low- and high-risk patients (p < 0.001). In the high-risk group, 77.3% of the patients died in <6 mo (p < 0.001). Palliative surgery and chemotherapy were associated with better survival, and the prognostic groups maintained statistical significance even when the same type of treatment was performed. In conclusion, the scoring system developed with variables related to patient performance status and clinical data was able to distinguish GC with PC with a high risk of 6-month mortality. Accordingly, verifying and validating our findings in a large cohort of patients is necessary to confirm and guarantee the external validation of the results. (AU)

• FAPESP's process: 20/13249-0 - Evaluation of intraperitoneal chemotherapy in treatment of gastric cancer in patients with peritoneal carcinomatosis
• Grantee: André Roncon Dias
• Support Opportunities: Regular Research Grants